Pharmabiz

Bayer receives Japanese approval for finerenone to treat patients with chronic heart failure

Bayer receives Japanese approval for finerenone to treat patients with chronic heart failure: Berlin Tuesday, December 23, 2025, 14:00 Hrs [IST] Bayer announced that Japan’s Min ...

Heart failure: Cardiologist highlights 5 subtle signs like swollen ankles that indicate your heart is weakening

Dr Pradeep highlights warning signs of heart failure, including increased urination at night, swollen ankles, and ...

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...

Ultromics Secures Strategic Investment from the American Heart Association's Go Red for Women Venture Fund™

Ultromics, a pioneer in AI-driven cardiology solutions, today announced an investment from the American Heart Association's Go Red for Women Venture Fund, a fund within American Heart Association ...
Medscape

Cracking HFpEF: Are Diagnostic Methods Evolving?

Once largely a diagnosis of exclusion, new tools and treatments are unraveling some of the mysteries surrounding heart failure with preserved ejection fraction.